Press Releases
ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests
3 June 2024
ARUP Laboratories is backing a federal lawsuit filed by the American Clinical Laboratory Association (ACLA) challenging the FDA's final rule to regulate laboratory-developed tests (LDTs) as medical devices. The lawsuit states that the FDA does not have legal authority over medical testing services from Congress and asserts that regulating these services is unreasonable. ARUP, one of the nation's four largest reference laboratories, with hospital and health system clients in
Read more...1 June 2024
Head for the Cure, the Musella Foundation For Brain Tumor Research & Information, and Cancer Commons today announced the launch of the Brain Cancer Support and Solutions Alliance to provide support, education, and guidance to brain cancer patients and their caregivers. Brain tumors present unique challenges, demanding specialized care from diagnosis through treatment. With a shared commitment to addressing these challenges, the Brain Cancer Support and Solutions Alliance will le
Read more...Inspira™ Technologies OXY B.H.N. a breakthrough medical technology company, announced today that Company President, Director, and co-founder, Mr. Joe Hayon, will discuss the Company's business targets, distribution agreements and next steps in a conference call to be held at 9:00am Eastern Time on Thursday, June 20, 2024. This follows the significant milestone of receiving FDA clearance for the INSPIRA™ ART100 system, as announced on May 28, 2024. Event Detai
Read more...30 May 2024
Stout, a leading global advisory firm, is pleased to announce the acquisition of HealthCare Appraisers, Inc., a premier provider of healthcare valuation and consulting services. HealthCare Appraisers has been a market leader in healthcare valuation for over two decades and brings unparalleled expertise and a proven track record of delivering exceptional service to its clients. This strategic move underscores Stout's commitment to expanding its healthcare valuation capabilities and further
Read more...The Society for Simulation in Healthcare (SSH), in collaboration with the Society for Simulation in Europe (SESAM), is proud to announce the release of the "Global Consensus Statement on Simulation-Based Practice in Healthcare." This groundbreaking statement, developed also in collaboration with representatives from 50 simulation societies across 67 countries, underscores the transformative power of simulation in healthcare education, training, and practice. The
Read more...Luma Health, creator of the market-leading Patient Success Platform™, has been selected by Modern Healthcare as one of the 2024 Best Places to Work in Healthcare. The award identifies and recognizes outstanding employers in the healthcare industry nationwide, and combines an assessment of a company's practices and policies with independent employee feedback. Luma Health's commitment to transforming the patient healthcare journey has not only attracted top talent in the
Read more...Aliter Capital has confirmed the rebranding of the integrated healthcare technology platform business in its Aliter Capital II fund. Previously known as Halcyon, the group is now Athera Healthcare, with a focus on combining the best technologies and people, to empower healthcare organisations to drive progress, improve operational efficiency and advance patient care. Aliter continues to work closely with Athera Healthcare’s management team to support further or
Read more...27 May 2024
AbbVie announced today that it has completed its acquisition of Landos Biopharma, With the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like receptor family), which is currently in Phase 2 for the treatment of moderate to severe UC (NEXUS study; NCT05785715). NLRX1 regulates immunometabolism and inflammation, and its activation may address inflammatory bowe
Read more...Nevro, a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on May 7, 2024, the Compensation Committee of the Company's Board of Directors granted inducement restricted stock unit awards covering 59,460 shares of Nevro's common stock to twenty-six new non-executive employees to induce them to accept employment with Nevro. Each award was granted under the Nevro Corp. 2023 Inducement Award Plan and ve
Read more...24 May 2024
Holista, LLC, a leader in value-based delivery and administration of healthcare services and OrthoForum Value Network (The OrthoForum Value Network), a national physician specialty organization whose membership includes many of the largest privately-owned orthopaedic practices in the United States, today announced a partnership through which Holista's value-based bundled services will be offered by participating providers in WI. Holista is dedicated to transforming the deli
Read more...
